For: | Fung J. Era of direct acting antivirals in chronic hepatitis C: Who will benefit? World J Hepatol 2015; 7(24): 2543-2550 [PMID: 26523206 DOI: 10.4254/wjh.v7.i24.2543] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i24/2543.htm |
Number | Citing Articles |
1 |
David Etoori, Sara Cococcia, Ankur Srivastava, Stuart Flanagan, Grainne Nixon, Satya Bobba, Alex Warner, Karen Sennett, Caroline Sabin, Sarah Morgan, William M. Rosenberg. The Camden and Islington Viral Hepatitis Identification Tool (CIVHIT): Use of a Clinical Database Case‐Finding Tool for Hepatitis B, Hepatitis C and HIV in Primary Care. Journal of Viral Hepatitis 2025; 32(4) doi: 10.1111/jvh.14027
|
2 |
David Etoori, Ruth Simmons, Monica Desai, Graham R. Foster, Avelie Stuart, Caroline Sabin, Sema Mandal, William Rosenberg. Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-19919-3
|
3 |
David Whiteley, Anne Whittaker, Lawrie Elliott, Sarah Cunningham-Burley. The lived experience of interferon-free treatments for hepatitis C: A thematic analysis. International Journal of Drug Policy 2016; 38: 21 doi: 10.1016/j.drugpo.2016.10.013
|
4 |
Kazem Baesi, Ali Akbar Velayati, Masoumeh Farrokh Ashtiani, Kamal Fakhredini, Mohammad Banifazl, Mona Sadat Larijani, Parya Basimi, Amitis Ramezani. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients. Current HIV Research 2021; 19(5): 391 doi: 10.2174/1566523221666210707142838
|
5 |
Sergio Estefan, Carlos Eduardo Brandão-Melo, Cintia Marques dos Santos Silva, Danilo Cosme Klein Gomes, Paula Cardoso, Marcia Helena S. Costa. Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.631600
|
6 |
Anna Krzeczkowska, Paul Flowers, Zoe Chouliara, Peter Hayes, Adele Dickson. ‘It’s been a long haul, a big haul, but we’ve made it’: hepatitis C virus treatment in post-transplant patients with virus recurrence: An interpretative phenomenological analysis. Health Psychology Open 2018; 5(2) doi: 10.1177/2055102918792673
|
7 |
Hiroji Shinkawa, Masaki Kaibori, Masaki Ueno, Satoshi Yasuda, Hisashi Ikoma, Tsukasa Aihara, Takuya Nakai, Masahiko Kinoshita, Hisashi Kosaka, Shinya Hayami, Yasuko Matsuo, Ryo Morimura, Takayoshi Nakajima, Chihoko Nobori, Takeaki Ishizawa. Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study. Liver Cancer 2024; : 1 doi: 10.1159/000540858
|
8 |
Angeline Oi‐Shan Lo, Henry Lik‐Yuen Chan, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong. Cost‐effectiveness of the highly effective direct‐acting antivirals in the treatment of chronic hepatitis C in Hong Kong. Journal of Gastroenterology and Hepatology 2017; 32(5): 1071 doi: 10.1111/jgh.13638
|
9 |
Jessica L. Petrick, Andrea A. Florio, Rohit Loomba, Katherine A. McGlynn. Have incidence rates of liver cancer peaked in the United States?. Cancer 2020; 126(13): 3151 doi: 10.1002/cncr.32794
|
10 |
Mohammad I. Saleh, Suhad Bani Melhim. A time-to-event analysis describing virologic response in patients with chronic hepatitis C infection. Journal of Chemotherapy 2019; 31(5): 274 doi: 10.1080/1120009X.2019.1609739
|
11 |
David Etoori, Monica Desai, Sema Mandal, William Rosenberg, Caroline A Sabin. A scoping review of media campaign strategies used to reach populations living with or at high risk for Hepatitis C in high income countries to inform future national campaigns in the United Kingdom. BMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08603-3
|